Could a Urine Sample One Day Track Mammary Cancer in Dogs?
Mammary cancer in dogs may one day be monitored through a simple urine sample, according to a study published in Frontiers in Veterinary Science. Researchers collected urine from 118 female dogs — some with mammary tumors, some healthy — and looked for chemical differences. They found that dogs with larger tumors had lower levels of a compound called hippurate in their urine. The overall differences were small, and these markers are not ready for use at the vet’s office yet. But the findings point toward a future where a urine test could help track tumor behavior without surgery or repeated imaging.
For owners of female dogs, especially those who are intact (not spayed), this kind of research matters. Mammary tumors are among the most common cancers in female dogs. Anything that might make monitoring easier and less invasive is worth following.
Why Tracking Mammary Tumors Is Complicated
Once a dog is diagnosed with a mammary tumor, the vet’s main tools are physical exams, imaging like ultrasound or X-rays, and — most importantly — removing the tumor and sending it to a laboratory. A pathologist looks at the tissue under a microscope (this is called histopathology) to find out whether the tumor is benign (not cancerous and unlikely to spread) or malignant (cancerous, with the ability to spread to other parts of the body).
That process works well, but it requires surgery. Following up over time — checking whether a tumor has returned or grown — usually means repeat visits and more procedures. Scientists are searching for biomarkers: measurable signals in the body that reflect what a cancer is doing. Urine is a very appealing place to look, because it’s easy to collect, non-invasive, and can be sampled as often as needed.
How the Study Was Set Up
The researchers enrolled 118 female dogs in the study:
- 71 dogs had confirmed mammary tumors (a mix of benign and malignant)
- 47 dogs were healthy female dogs used as a comparison group
Urine samples were collected from all the dogs. Researchers then used a method called metabolomics — think of it as taking a detailed chemical inventory of a urine sample, listing every small molecule present and how much of each. The goal was to find compounds whose levels differed based on whether a dog had a tumor, how big that tumor was, and whether it was malignant.
What Researchers Found
The Biggest Signal Came From Tumor Size
Comparing all tumor-bearing dogs to healthy dogs, the urine profiles were not dramatically different. The differences were limited overall — which is a meaningful finding in itself, telling researchers that mammary cancer does not flood the urine with obvious chemical signals.
However, when the team focused specifically on tumor size and malignancy, a pattern appeared. Dogs with large mammary tumors had notably lower levels of hippurate in their urine.
Hippurate (hip-YOU-rate) is a naturally occurring compound that forms when the body breaks down certain plant-based foods and byproducts from gut bacteria. Lower levels can reflect changes in gut bacteria populations or in how the body is processing nutrients — both of which may be affected when a large tumor is present. Think of it like this: a big tumor may quietly shift the body’s chemistry in ways that eventually show up even in urine.
The study also found that certain other urinary metabolites (small chemical compounds) were associated with tumor malignancy, though those signals were also subtle.
These Findings Are a Starting Point, Not a Finished Tool
The researchers were clear that this is exploratory work. The signals found are real but modest — not yet strong or consistent enough to tell vets anything reliable about an individual dog’s cancer. A lot more research is needed before urine metabolomics becomes a clinical tool. Right now, it is a promising direction, not a test you can request.
What This Research Means for Your Dog’s Care
The Goal: Easier Monitoring Down the Road
The longer-term promise here is non-invasive cancer monitoring. If researchers can identify and validate urine markers that reliably reflect mammary tumor size or malignancy, it could eventually change follow-up care. Rather than relying solely on surgery and imaging to track how a tumor behaves over time, vets might one day supplement that with a urine test — one a dog owner could even collect at home.
This would be especially helpful for older or medically fragile dogs who don’t tolerate anesthesia or repeated procedures well.
What to Do Right Now
This study does not produce any test or action you can take today. The markers it identified are not validated for clinical use. If your dog has been diagnosed with a mammary tumor, continue following your vet’s recommendations — surgery, histopathology, and follow-up care remain the standard approach.
When to Get Your Dog Checked
The best action you can take now is to stay alert and catch any lumps early. Contact your veterinarian if you notice:
- A lump or swelling along your dog’s belly or chest, especially near the nipple line
- Any firmness, changes in shape, or discharge from a nipple
- A lump that seems to be growing or feels fixed to the tissue beneath it
- Unexplained weight loss, reduced appetite, or decreased energy
Mammary tumors are most common in intact female dogs, but spayed females can develop them too. Early detection — before a tumor grows large — gives your vet the best options for treatment.
Study Limitations
This was a small, exploratory study, and its authors acknowledged the constraints. With 71 tumor-bearing dogs and 47 controls, the dataset was not large enough to set reliable thresholds or draw firm conclusions. The dogs also varied in breed, age, and tumor type, which makes it harder to separate cancer-related urine changes from differences caused by diet, gut health, or other individual factors. Larger, more controlled studies are needed to confirm which metabolites are truly meaningful and how well they hold up across different dogs and tumor types.
The Bottom Line
A study of 118 female dogs found a small but real association between larger mammary tumors and lower urine hippurate levels — a signal that urine chemistry may one day help monitor mammary cancer in dogs without invasive procedures. The science is early, the sample was modest, and the markers are not yet ready for the clinic. But it is a meaningful first step.
For dog owners today, regular veterinary check-ups and prompt reporting of any new lumps remain your best tools. Mammary cancer caught early is far more treatable — and this research helps build toward a future where tracking it will be easier for everyone, dogs included.
This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.